Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids
Melissa B. Weimer, Andrew A. Herring, Sarah Kawasaki, et al.
Journal of Addiction Medicine (2023) Vol. 17, Iss. 6, pp. 632-639
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl
Leslie W. Suen, Amy Yunyu Chiang, Benjamin L. Jones, et al.
JAMA Network Open (2025) Vol. 8, Iss. 1, pp. e2456253-e2456253
Open Access | Times Cited: 3
Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl
Honora Englander, Ashish P. Thakrar, Sarah M. Bagley, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 6, pp. 691-691
Closed Access | Times Cited: 10
The association between buprenorphine doses above 16 milligrams and treatment retention in a multi‐payer national sample in the United States, 2014 to 2021
Erin J. Stringfellow, Huiru Dong, Seyedeh Nazanin Khatami, et al.
Addiction (2025)
Closed Access | Times Cited: 1
Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality
Feitong Lei, Michelle R. Lofwall, Jana McAninch, et al.
Journal of Addiction Medicine (2024) Vol. 18, Iss. 3, pp. 319-326
Open Access | Times Cited: 5
Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl
Ashish P. Thakrar, Paul J. Christine, Andrew Siaw-Asamoah, et al.
JAMA Network Open (2024) Vol. 7, Iss. 9, pp. e2435895-e2435895
Open Access | Times Cited: 5
A scoping review and consensus recommendations for emergency medical services buprenorphine (EMS-Bupe) programs
Anjni Joiner, Jessica Wanthal, Angela N. Murrell, et al.
Prehospital Emergency Care (2025), pp. 1-33
Closed Access
Treatment of Inpatient Opioid Withdrawal with Short-Acting Full Agonist Opioids at a Safety-Net Hospital
Gabriela Steiner, Leslie W. Suen, Marlene Martín, et al.
Journal of General Internal Medicine (2025)
Open Access
Low-Dose Initiations of Buprenorphine in the Fentanyl Era—A Search for Evidence-Based Approaches to an Evolving Crisis
J. Edward Berk, Michael Rose, Ashish P. Thakrar
JAMA Network Open (2025) Vol. 8, Iss. 1, pp. e2456261-e2456261
Open Access
Case Series: Magnitude and duration of fentanyl and xylazine detection in the urine of persons with opioid use disorder
Helen Bird, William Clarke, Craig W. Hendrix, et al.
American Journal on Addictions (2025)
Closed Access
“It’s within your own power”: shared decision-making to support transitions to buprenorphine
Beth E. Williams, Stephen A. Martin, Kim Hoffman, et al.
Addiction Science & Clinical Practice (2025) Vol. 20, Iss. 1
Open Access
Comparative effectiveness of extended‐release naltrexone versus buprenorphine‐naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population‐based observational data
Sara Lodi, Shapei Yan, Benjamin J. Bovell-Ammon, et al.
Addiction (2025)
Closed Access
Uptake of Low-dose Buprenorphine Initiation and Associated Patient Characteristics in British Columbia, Canada: A Population-based Cohort Study
Nikki Bozinoff, Jingxin Lei, Tamara Mihic, et al.
Journal of Addiction Medicine (2025)
Closed Access
Commentary on Young et al.: Clinical guidance is required for stimulant co‐prescription with opioid agonist therapy
Nadine Ezard, Krista J. Siefried, Brendan Clifford
Addiction (2025)
Open Access
Initiation of extended-release buprenorphine in emergency department patients: A retrospective cohort study
Louisa Marion-Bellemare, Anita Srivastava, Julie Samson, et al.
The American Journal of Emergency Medicine (2025)
Closed Access
Cross-sectional examination of characteristics of higher-dose buprenorphine prescriptions during the era of illicit fentanyl
Bradley D. Stein, Flora Sheng, Brendan Saloner, et al.
Addiction Science & Clinical Practice (2025) Vol. 20, Iss. 1
Open Access
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review
Kathleen K. Adams, Kristin Waters, Diana M Sobieraj
Addiction Science & Clinical Practice (2025) Vol. 20, Iss. 1
Open Access
Overview of best practices for buprenorphine initiation in the emergency department
Terence M. Hughes, Nicholas Nasser, Avir Mitra
International Journal of Emergency Medicine (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Patients' Perspectives on Discontinuing Buprenorphine for the Treatment of Opioid Use Disorder
Jessica J. Wyse, Alison Eckhardt, Dylan Waller, et al.
Journal of Addiction Medicine (2024) Vol. 18, Iss. 3, pp. 300-305
Closed Access | Times Cited: 3
High-Dose Buprenorphine Initiation: A Scoping Review
Stanley Wong, Nicholas Fabiano, Declan Webber, et al.
Journal of Addiction Medicine (2024) Vol. 18, Iss. 4, pp. 349-359
Closed Access | Times Cited: 3
Fentanyl, carfentanil and other fentanyl analogues in Canada’s illicit opioid supply: A cross-sectional study
Robert A. Kleinman
Drug and Alcohol Dependence Reports (2024) Vol. 12, pp. 100240-100240
Open Access | Times Cited: 3
Reconsidering the usefulness of long-term high-dose buprenorphine
Lakshit Jain, Thomas W. Meeks, Christopher K. Blazes
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs
John J. Mariani, Robert L. Dobbins, Amy Heath, et al.
American Journal on Addictions (2023) Vol. 33, Iss. 1, pp. 8-14
Open Access | Times Cited: 6
Management of Critically Ill Patients Receiving Medications for Opioid Use Disorder
Brian L. Erstad, Melody Glenn
CHEST Journal (2023) Vol. 165, Iss. 2, pp. 356-367
Closed Access | Times Cited: 5
Harm reduction in undergraduate and graduate medical education: a systematic scoping review
Kelsey Smith, Nina K. Shah, Abby Adamczyk, et al.
BMC Medical Education (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Buprenorphine for Opioid Use Disorder—An Essential Medical Treatment
Melissa B. Weimer, Kenneth L. Morford
JAMA Internal Medicine (2024) Vol. 184, Iss. 10, pp. 1248-1248
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top